AstraZeneca said today it has launched a 30,000-patient Phase III trial in the U.S. of AZD1222, the COVID-19 vaccine it…
Super UserSeptember 8, 2020
WASHINGTON, D.C., August 27, 2020 - Johnson & Johnson Innovation LLC today announced the first companies to be part of…
Super UserSeptember 8, 2020
HIV therapies, typically cocktails of antiviral drugs, have proven to be very successful in controlling HIV/AIDS. However, they are not…
Super UserSeptember 8, 2020
GAITHERSBURG, Md., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it is teaming up…
Super UserSeptember 8, 2020
Vaccitech Ltd, a clinical-stage biopharmaceutical company developing immunotherapies to treat and prevent infectious diseases and cancer, announces that the development…
Super UserSeptember 8, 2020
ROCKVILLE, Md., Sept. 1, 2020 /PRNewswire/ -- Emmes today announced that Jonathan DeCarlo has been promoted to chief financial officer. DeCarlo,…
Super UserSeptember 8, 2020
BALTIMORE (WJZ) — As the fall semester begins, Johns Hopkins University wants to make sure its students are protected. They…
Super UserSeptember 8, 2020
ROCKVILLE, Md. & SAN DIEGO–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid…
Super UserSeptember 8, 2020
Don't miss your change to be named the BioHealth Startup with the Most Commectial Potential at the BHCR Forum, win…
Super UserSeptember 8, 2020